TAG:
laboratories
IMPATH Delisted by Nasdaq, Under Investigation by SEC
By Robert Michel | From the Volume X No. 12 – September 8, 2003 Issue
EFFECTIVE AUGUST 27, Nasdaq Stock Market, Inc. delisted the stock of IMPATH, Inc. Less than a week earlier, IMPATH had disclosed that it was under investigation by the Securities and Exchange Commission (SEC). IMPATH can truly be described as a comp…
20% Medicare Co-Pay A Blow to Regional Labs
By Robert Michel | From the Volume X No. 12 – September 8, 2003 Issue
CEO SUMMARY: Informed speculation indicates that private health insurers are likely to adopt some form of laboratory test co-payment if the proposed Medicare 20% lab test co-pay legislation becomes law. For hospital laboratory outreach programs, the resulting reduction of reimbursement an…
“September 8, 2003 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume X No. 12 – September 8, 2003 Issue
Early last week, Laboratory Corporation of America announced an out-of-court settlement in its lawsuit involving its subsidiary, DIANON Systems, Inc. As plaintiff, DIANON had sued five former DIANON employees and their new company, DiaPath LLC. The c…
Major Events Hit Pathology Profession
By R. Lewis Dark | From the Volume X No. 11 – August 18, 2003 Issue
ACROSS THE AMERICAN HEALTHCARE SYSTEM, numerous trends tug at pathologists and the laboratory medicine services they provide. Both clinical pathologists and anatomic pathologists find themselves confronted with a growing number of demands for change. Increasingly these demands can no longer be ignore…
National Lab Standards Coming For Patient Safety
By Robert Michel | From the Volume X No. 11 – August 18, 2003 Issue
CEO SUMMARY: Because lab test data plays such an important role in medical decision-making, the Centers for Disease Control and Prevention (CDC) has launched a national effort to evaluate the quality of clinical and public health laboratories. In forming a Quality Institute, the goal is t…
Gauging The Impact Of Lab Patient Safety
By Robert Michel | From the Volume X No. 11 – August 18, 2003 Issue
CEO SUMMARY: Within 18 months, the Laboratory Quality Institute plans to issue a national report on the quality of laboratory services. Not only will this bring a new level of public attention and scrutiny to clinical laboratory operations, but it will require everyone involved in deliver…
Last Week’s Power Outage Affects Labs in Many Regions
By Robert Michel | From the Volume X No. 11 – August 18, 2003 Issue
EVERY AFFECTED LABORATORY knows the precise time. Somewhere between 4:00 and 4:15 P.M. EST last Thursday is when the local power company stopped feeding electricity in cities ranging from New York City west to Toledo, Detroit and parts of Canada. As of press time, many labs in affected cities lacked…
First ISO-Designed Clinical Lab Improves Outcomes, Costs
By Robert Michel | From the Volume X No. 11 – August 18, 2003 Issue
CEO SUMMARY: In the first 14 months of operation, Kaiser Permanente Northwest’s new automated regional laboratory facility, the nation’s first designed by an ISO-9000-certified lab organization, is yielding big gains in both productivity and outcomes. In its high-volume core lab, prod…
ARUP Laboratories, Ascension Health, IMPATH
By Robert Michel | From the Volume X No. 11 – August 18, 2003 Issue
ARUP SNAGS MAJOR HOSPITAL SEND-OUT PACT WITH ASCENSION HEALTH FOLLOWING AN EXHAUSTIVE RFP PROCESS, Ascension Health has selected ARUP Laboratories, Inc. to be its sole source provider of reference laboratory testing. This national agreement covers all 67 h…
“August 18, 2003 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume X No. 11 – August 18, 2003 Issue
Recently Laboratory Corporation of America recruited and rehired three DIANON sales reps who had left the company following its acquisition by LabCorp earlier this year. On its second quarter conference call, LabCorp officials, under criticism for numerous departures of DIANON sales …
CURRENT ISSUE

Volume XXXII, No. 10 – July 14, 2025
This issue is strong on different flavors of enforcement that clinical laboratories, whether they want to or not, will need to contend with. Lab stakeholders provide insights that medical labs need to brace for more action to counter pending test reimbursement rate cuts under PAMA. Also, this issue provides the legal and regulatory landscape for clinical labs’ use of AI and how it evolves with the technology. AI is creating legal uncertainty for clinical labs, especially around data privacy and FDA oversight of AI tools in diagnostics.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized